IdentifAI Genetics

Noninvasive Prenatal Testing for Genetic Disorders

Health Tech & Life Sciences
Active
Seed Rosh Haayin, Israel Founded 2020
Last updated 2026-06-18
Total raised
$10.3M
Last: 2026-05
Stage
Seed
Founded
2020
Headcount
14
HQ
Rosh Haayin, Israel
Sector
Health Tech & Life Sciences

About

Identifai Genetics is developing a noninvasive prenatal test for the early detection of single-gene disorders. Using a simple first-trimester maternal blood test to access the entire embryonic genome, Identifai can perform a comprehensive analysis capable of detecting every single-point mutation, insertion-deletion, and structural variation in order to identify severe genetic disorders. Identifais core suite of algorithms, the Hoobari paradigm, is a patent-pending proprietary methodology developed for five years at Tel Aviv University. The technology has demonstrated high accuracy in detecting a wide variety of mutations in real-life cases, and the company is planning to launch clinical studies. Identifai Genetics is dedicated to providing solutions that will enable safe pregnancies for all families, everywhere.

Funding history · 7 rounds · $10.3M total

2026-05
2024-07
$1.0M
2023-04
2021-12
$750K
2021-10
2021-01
Pre-Seed $400K

Q&A

What is IdentifAI Genetics' primary focus?
IdentifAI Genetics is developing a noninvasive prenatal test for the early detection of single-gene disorders using a first-trimester maternal blood test.
When was IdentifAI Genetics founded?
IdentifAI Genetics was founded in November 2020.
What is the current employee count for IdentifAI Genetics?
IdentifAI Genetics has 11-50 employees.
What is the total amount of funding IdentifAI Genetics has raised to date?
IdentifAI Genetics has raised a total of $10,250,000.
Which investor participated in IdentifAI Genetics' Pre-Seed round in January 2021?
Shizim Group was a lead investor in IdentifAI Genetics' Pre-Seed round in January 2021.
Which entity provided a grant to IdentifAI Genetics in February 2023?
The Israel Innovation Authority provided a $2,500,000 grant to IdentifAI Genetics in February 2023.
Who led IdentifAI Genetics' Seed funding round in April 2023?
eHealth Ventures led IdentifAI Genetics' Seed funding round in April 2023.
What is the most recent grant IdentifAI Genetics received, and from whom?
IdentifAI Genetics received a $1,000,000 grant from the BIRD Foundation in May 2026.
Who are the co-founders of IdentifAI Genetics?
The co-founders of IdentifAI Genetics are Yossi Bornstein, Noam Shomron, and Oren Tadmor.
What is the core technology developed by IdentifAI Genetics?
IdentifAI Genetics' core technology is the Hoobari paradigm, a patent-pending methodology developed at Tel Aviv University, used for comprehensive genetic analysis.

Team · 6

Founder · Chairman
LinkedIn ↗
Founder · Co-founder & CSO
LinkedIn ↗
Founder · Co-founder & Head of Product
LinkedIn ↗
Chief of Operations
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsGenesArtificial IntelligenceMachine LearningDeep Learning
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesLaboratoriesPatientsProvidersLife SciencesBiotechnology
Business model
B2B2CB2B

Highlights

1 PatentsVerified

Tags

femtechpregnancygeneticsmachine-learningdeep-learningdiagnosticsartificial-intelligencewomen-healthbiotechnologygenetic-disordersnon-invasivebabiesblood-testearly-detectionhealthcare-providerswomenpharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)